PETRONI, MARIA LETIZIA
 Distribuzione geografica
Continente #
NA - Nord America 4.426
AS - Asia 3.934
EU - Europa 3.073
SA - Sud America 323
AF - Africa 233
OC - Oceania 3
Totale 11.992
Nazione #
US - Stati Uniti d'America 4.357
SG - Singapore 1.384
CN - Cina 1.213
IT - Italia 877
GB - Regno Unito 559
VN - Vietnam 423
DE - Germania 362
HK - Hong Kong 310
BR - Brasile 246
SE - Svezia 246
NL - Olanda 218
IN - India 206
KR - Corea 205
RU - Federazione Russa 177
FR - Francia 132
IE - Irlanda 117
BG - Bulgaria 67
ZA - Sudafrica 65
SC - Seychelles 59
CI - Costa d'Avorio 57
AT - Austria 52
FI - Finlandia 50
UA - Ucraina 50
EE - Estonia 39
JP - Giappone 39
ID - Indonesia 37
CA - Canada 33
AR - Argentina 31
PL - Polonia 26
MX - Messico 24
CH - Svizzera 22
IQ - Iraq 19
BE - Belgio 18
ES - Italia 18
TR - Turchia 17
EC - Ecuador 16
NG - Nigeria 15
BD - Bangladesh 13
CL - Cile 12
JO - Giordania 11
EG - Egitto 10
PK - Pakistan 9
TG - Togo 9
CZ - Repubblica Ceca 7
RO - Romania 7
DK - Danimarca 6
GR - Grecia 6
PY - Paraguay 6
SA - Arabia Saudita 6
CO - Colombia 5
DO - Repubblica Dominicana 5
DZ - Algeria 5
PH - Filippine 5
TW - Taiwan 5
UZ - Uzbekistan 5
IR - Iran 4
LT - Lituania 4
MY - Malesia 4
NO - Norvegia 4
NP - Nepal 4
AE - Emirati Arabi Uniti 3
HN - Honduras 3
PE - Perù 3
UY - Uruguay 3
AL - Albania 2
IL - Israele 2
KE - Kenya 2
MA - Marocco 2
MD - Moldavia 2
PT - Portogallo 2
RS - Serbia 2
AO - Angola 1
AU - Australia 1
AZ - Azerbaigian 1
BN - Brunei Darussalam 1
BO - Bolivia 1
BW - Botswana 1
BZ - Belize 1
GE - Georgia 1
GT - Guatemala 1
KG - Kirghizistan 1
KI - Kiribati 1
KW - Kuwait 1
LB - Libano 1
LC - Santa Lucia 1
LK - Sri Lanka 1
LY - Libia 1
MK - Macedonia 1
ML - Mali 1
MU - Mauritius 1
NZ - Nuova Zelanda 1
OM - Oman 1
SD - Sudan 1
SN - Senegal 1
TH - Thailandia 1
TJ - Tagikistan 1
TN - Tunisia 1
TT - Trinidad e Tobago 1
ZM - Zambia 1
Totale 11.992
Città #
Singapore 895
Ashburn 600
Southend 454
Fairfield 434
Hefei 386
Hong Kong 306
Santa Clara 274
Seattle 230
Woodbridge 226
Chandler 202
Seoul 202
Houston 185
Dallas 180
Wilmington 158
Bologna 155
Cambridge 153
Beijing 152
Princeton 143
Boardman 127
Dublin 117
Ann Arbor 97
Milan 88
Ho Chi Minh City 87
Hanoi 85
Los Angeles 70
Turin 68
Sofia 67
Dong Ket 58
Abidjan 57
Westminster 52
Rome 50
Redondo Beach 46
New York 45
Buffalo 42
Nanjing 40
Bengaluru 39
Tokyo 39
Vienna 39
Berlin 31
Helsinki 29
Frankfurt am Main 28
San Diego 26
Redmond 25
São Paulo 25
Saint Petersburg 24
Munich 23
Shenyang 23
Falkenstein 22
Jakarta 21
London 21
Shanghai 20
Des Moines 19
Jacksonville 19
Jinan 19
Naples 19
Amsterdam 18
Brussels 18
Dearborn 18
Guangzhou 18
Düsseldorf 17
Medford 16
Abeokuta 15
Olalla 15
Padova 15
Tongling 15
Denver 14
Nuremberg 14
Phoenix 14
Cesena 13
Genoa 13
Warsaw 13
Zhengzhou 13
Chicago 12
Haiphong 12
Hebei 12
Lappeenranta 12
Montreal 12
Nanchang 12
Parma 12
San Francisco 12
Biên Hòa 11
Castel Maggiore 11
Changsha 11
Council Bluffs 11
Norwalk 11
Rimini 11
Yubileyny 11
Amman 10
Atlanta 10
Da Nang 10
Falls Church 10
Jiaxing 10
Ningbo 10
Tianjin 10
Ankara 9
Bari 9
Brooklyn 9
Chengdu 9
Florence 9
Hangzhou 9
Totale 7.598
Nome #
L’assistenza al paziente grande obeso con disabilita’ 217
Determinants of weight, psychological status, food contemplation and lifestyle changes in patients with obesity during the COVID-19 lockdown: a nationwide survey using multiple correspondence analysis 195
Dietary habits and neurological features of Parkinson's disease patients: Implications for practice 190
Healthcare resource utilization and costs of nonalcoholic steatohepatitis patients with advanced liver disease in Italy 188
The Impact of GLP-1 Receptor Agonists (GLP-1 RAs) on Mental Health: A Systematic Review 184
Dietary habits in Parkinson's disease: Adherence to Mediterranean diet 183
An all-natural, very low-calorie ketogenic diet (VLCKD) protocol has similar efficacy and safety to commercial meal replacements (whole or partial) in inducing weight loss: results from a prospective, controlled, 4-arm pragmatic trial (KOBE trial) 175
Pulsed Electromagnetic Field (PEMF) stimulation as an adjunct to exercise: a brief review 174
Psychological distress in morbid obesity in relation to weight history 173
La riabilitazione in ambito metabolico 170
Diabetes and NAFLD: a high-risk cohort with definite therapeutic potential 167
Promoting weight loss and psychological well-being in patients with obesity: A sequential combination of behavioural lifestyle intervention and well-being therapy 163
Combination of GLP-1 receptor agonists and behavioural treatment in type 2 diabetes elicits synergistic effects on body weight: A retrospective cohort study 153
Lifestyle changes for the treatment of nonalcoholic fatty liver disease-a 2015-19 update 149
Long-term follow-up of web-based and group-based behavioural intervention in NAFLD in a real world clinical setting 148
Association between Albumin Alterations and Renal Function in Patients with Type 2 Diabetes Mellitus 148
Analysis of sedentary behaviors, eating habits, and psychological well-being in Italian adolescents 146
Lifestyle Intervention in NAFLD: Long-Term Diabetes Incidence in Subjects Treated by Web- and Group-Based Programs 145
Stress Hyperglycemia and Complications Following Traumatic Injuries in Individuals With/Without Diabetes: The Case of Orthopedic Surgery 145
Clinical and psychological correlates of health-related quality of life in obese patients 144
Weight loss expectations in obese patients and treatment attrition: an observational multicenter study 143
Comparative long-term mortality after laparoscopic adjustable gastric banding versus nonsurgical controls 142
Real-life prevalence of Metabolic Associated Fatty Liver Disease (NAFLD) and non-alcoholic steatohepatitis (NASH) in a tertiary obesity clinic in Italy 140
Searching food during the night: the role of video-polysomnography in the characterization of the night eating syndrome 140
Real-world prevalence of metabolic associated fatty liver disease (MAFLD) and fibrotic-non-alcoholic steatohepatitis (NASH) in patients with obesity (PwO) in an outpatient specialist clinic in Italy 139
Moderate Alcohol Intake in Non-Alcoholic Fatty Liver Disease: To Drink or Not to Drink? 138
Weight management, psychological distress and binge eating in obesity. A reappraisal of the problem 136
Muscle uncoupling protein 3 expression is unchanged by chronic ephedrine/caffeine treatment: Results of a double blind, randomised clinical trial in morbidly obese females 135
Weight Loss Expectations and Attrition in Treatment-Seeking Obese Women 134
Long-term treatment of severe obesity: are lifestyle interventions still an option? 133
Liraglutide 3.0 mg and mental health: can psychiatric symptoms be associated to adherence to therapy? Insights from a clinical audit 132
The effect of lutein on eye and extra-eye health 131
Effects of an intensive inpatient rehabilitation program in elderly patients with obesity 131
Expected benefits and motivation to weight loss in relation to treatment outcomes in group-based cognitive-behavior therapy of obesity 129
Dysfunctional eating in type 2 diabetes mellitus: A multicenter Italian study of socio-demographic and clinical associations 129
Burden of non-alcoholic fatty liver disease and usefulness of non-invasive tests to identify advanced liver disease in patients with type 2 diabetes mellitus: interimanalysis of an Italian prospective multicentre study 128
Prevention and Treatment of Sarcopenic Obesity in Women 128
Fatty liver in pregnancy: a narrative review of two distinct conditions 128
Personality, attrition and weight loss in treatment seeking women with obesity 127
Chronic Care Models for Obesity Management 126
Risk of binge eating disorder in patients with metabolic dysfunction-associated steatotic liver disease 125
Data architecture framework for improving consumer awareness in food shopping experience 124
Maternal PKU: Defining phenylalanine tolerance and its variation during pregnancy, according to genetic background 123
Obesity and Eating Disorders. Indications for the different levels of care. An Italian Expert Consensus Document Documento di Consensus. Obesità e Disturbi dell’Alimentazione Indicazioni per i diversi livelli di trattamento a,b,c,d,e [Obesity and Eating Disorders. Indications for the different levels of care. An Italian Expert Consensus Document] 121
Adipose tissue-associated cancer risk: Is it the fat around the liver, or the fat inside the liver? 121
Motivational interviewing adapted to group setting for the treatment of relapse in the behavioral therapy of obesity. A clinical audit 121
The Role of Psychological Well-Being in Weight Loss: New Insights from a Comprehensive Lifestyle Intervention 121
Breakthrough in the Treatment of Metabolic Associated Steatotic Liver Disease: Is it all over? 120
Circulating ghrelin level is increased in coeliac disease as in functional dyspepsia and reverts to normal during gluten-free diet 119
Dati preliminari sullo studio della sintomatologia ortoressica tra pazienti diabetici affetti da epatopatia. 119
Rehabilitation in obesity with comorbidities: A consensus document from experts of the Italian Society of Physical and Rehabilitation Medicine (SIMFER), the Italian Society of Obesity (SIO) and the Italian Society of Eating Disorders (SISDCA) 117
Nutrition in patients with type 2 diabetes: Present knowledge and remaining challenges 114
Development and application of a simple and powerful tool for nutrition and lifestyle education for the Italian general population by general practitioners and family paediatricians 113
Gait analysis in anorexia and bulimia nervosa 112
Management of non-alcoholic fatty liver disease 110
Osteosarcopenia in NAFLD/MAFLD: An Underappreciated Clinical Problem in Chronic Liver Disease 109
Effect of pulsed electromagnetic fields (PEMFs) on oxygen saturation during a constant-load exercise in overweight people 109
Principles and protocols in Nutritional Rehabilitation 109
The treatment of diabetes in advanced liver disease: change of a paradigm 108
Binge eating disorder in obesity: comparison of different therapeutic strategies 108
Weight cycling and cardiovascular risk factors in obesity 108
Obesity and NAFLD: Same problem? 107
Anxiety and depression in metabolic-associated steatotic liver disease: relation with socio-demographic features and liver disease severity 106
Prevalence and burden of obesity in Rehabilitation Units in Italy: a survey 104
Gliomi, neuroglioblastomi e dieta chetogenica negli adulti: una overview di revisioni sistematiche 103
Hospitalization rates and cost in severe or complicated obesity: An Italian cohort study 103
TECNOB study: Ad interim results of a randomized controlled trial of a multidisciplinary telecare intervention for obese patients with type-2 diabetes 102
Undernutrition, risk of malnutrition and obesity in gastroenterological patients: A multicenter study 101
Metformin and the Liver: Unlocking the Full Therapeutic Potential 101
Sporadic mutations in melanocortin receptor 3 in morbid obese individuals 99
Long-term mortality in a cohort of severely obese persons in Italy 99
Safety and efficacy of therapy with botulinum toxin in obesity: a pilot study 98
Caloric input is inadequate in predicting the presence of liver steatosis and fibrosis in a population adhering to a screening program for metabolic syndrome 96
Risk of suicide and bariatric surgery 96
TECNOB: study design of a randomized controlled trial of a multidisciplinary telecare intervention for obese patients with type-2 diabetes 94
Body composition in Parkinson's disease 94
Balance in patients with anorexia and bulimia nervosa 93
Effects of antidiabetic agents on steatosis and fibrosis biomarkers in type 2 diabetes: A real-world data analysis 93
NASH: A glance at the landscape of pharmacological treatment 89
Effect of physical exercise on postural control in diabetic subjects 89
Weight loss and clinical characteristics of young adults patients seeking treatment at medical centers: Data from the QUOVADIS Study 88
Validation of food frequency questionnaire for assessing dietary macronutrients and calcium intake in Italian children and adolescents 86
The Effect of Liraglutide on β-Blockade for Preventing Variceal Bleeding: A Case Series 86
La prevenzione dell'obesità genetica 85
Non-alcoholic fatty liver disease in adults 2021: A clinical practice guideline of the Italian Association for the Study of the Liver (AISF), the Italian Society of Diabetology (SID) and the Italian Society of Obesity (SIO) 85
Considerations when prescribing pharmacotherapy for metabolic associated fatty liver disease 80
Promoting positive mental health for sustainable eating behaviors: the PROMISE study in patients with obesity 78
Management of Diabetes in Candidates for Liver Transplantation and in Transplant Recipients 77
Ketogenic enteral nutrition for weight loss: a word of warning 75
Prevalence of orthorexic traits in type 2 diabetes mellitus: at the crossroads between nutritional counseling and eating disorders 74
Obesità e farmaci 69
Non-alcoholic fatty liver disease: Not time for an obituary just yet! 69
'Effect of exercise training on postural control in people with diabetes 67
Non-alcoholic fatty liver disease in adults 2021: A clinical practice guideline of the Italian Association for the Study of the Liver (AISF), the Italian Society of Diabetology (SID) and the Italian Society of Obesity (SIO) 66
Rationale for hospital-based rehabilitation in obesity with comorbidities 62
RANK-RANKL-OPG Axis in MASLD: Current Evidence Linking Bone and Liver Diseases and Future Perspectives 61
La valutazione degli indicatori di processo e outcome per confermare la validità della proposta operativa 60
La Neurofarmacologia dell'obesità: presente e futuro. Il punto di vista del clinico 56
A psycho-educational intervention for the prevention of foot lesions in people with diabetes: Report of a clinical audit 55
Exercise-induced changes in postural stability among patients with diabetes 51
Totale 11.754
Categoria #
all - tutte 37.469
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 37.469


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021638 0 0 0 0 0 186 56 24 79 64 25 204
2021/20221.139 67 51 62 28 118 74 16 132 56 45 274 216
2022/20231.296 105 143 59 143 94 107 62 87 226 50 133 87
2023/2024553 33 70 38 43 51 115 24 54 14 31 32 48
2024/20252.911 94 291 227 249 418 137 181 118 104 303 195 594
2025/20263.750 599 783 744 688 626 310 0 0 0 0 0 0
Totale 12.285